Biological Pacemakers
Author Information
Author(s): Rajesh G, Francis Johnson
Primary Institution: Department of Cardiology, Medical College Hospital, Calicut, Kerala, India
Hypothesis
Genetically engineered pacemakers could be a possible alternative to implantable electronic devices for the treatment of bradyarrhythmias.
Conclusion
Molecular approaches to developing biological pacemakers show promise but face challenges such as longevity and stability.
Supporting Evidence
- Gene therapy can convert cardiac myocytes into pacemaker cells.
- Stem cell therapy may provide a more stable delivery system for pacemaker genes.
- Local expression of HCN2 can create sufficient pacemaker current to drive the heart.
Takeaway
Scientists are trying to create new types of heart pacemakers using genes instead of batteries, but there are still some problems to solve.
Methodology
The study discusses various molecular approaches including gene therapy and stem cell therapy to create biological pacemakers.
Potential Biases
Use of viruses in gene therapy carries risks of carcinogenicity and infectivity.
Limitations
Challenges include the longevity of pacemaker function, potential for neoplasia, and the need for optimal cell mass and coupling.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website